Porphyrin nanovesicles
AssigneeUniversity Health Network
InventorsGang Zheng, Jonathan F. Lovell
Life of this patent
Estimating the term…
Abstract
The application relates to a nanovesicle comprising a bilayer of at least 15 mol % porphyrin-phospholipid conjugate, wherein the conjugate comprises a porphyrin, porphyrin derivative or porphyrin analog covalently attached to the phospholipid side chain. The nanovesicle can be used for photothermal therapy, photoacoustic imaging, and fluorescence imaging. The application also discloses a method of preparing the said nanovesicle.
Claims35
A nanovesicle comprising a bilayer of at least 15 molar % porphyrin-phospholipid conjugate, wherein the porphyrin-phospholipid conjugate comprises one porphyrin, porphyrin derivative or porphyrin analog covalently attached to a lipid side chain, preferably at the sn-1 or the sn-2 position, of one phospholipid.
3-10. (canceled)
(canceled)
A method of preparing a nanovesicle, comprising:
- a. mixing a porphyrin-phospholipid conjugate in buffer, wherein the porphyrin-phospholipid conjugate comprises one porphyrin, porphyrin derivative or porphyrin analog covalently attached to a lipid side chain, preferably at the sn-1 and/or the sn-2 position, of one phospholipid;
- b. extruding or sonicating the mixture of step (a) to yield a porphyrin-phospholipid bilayer nanovesicle comprising a bilayer of at least 15 molar % porphyrin-phospholipid conjugate.
(canceled)
41-46. (canceled)
Dependencies are inferred from the claim text.